Dr. Samy Suissa is Director of the Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, and Professor, Departments of Epidemiology and Biostatistics and of Medicine, McGill University. Dr. Suissa also heads the McGill Pharmacoepidemiology Research Unit. He was the founding Director of the Quebec Research Network on Medication Use, funded by the FRSQ.
Dr. Suissa has chaired and served on several review committees for the Fonds de la recherche en santé du Québec (FRSQ) and the Canadian Institutes of Health Research (CIHR), and on the External Advisory Board of PROTECT, the drug safety consortium formed by the European Innovative Medicines Initiative (IMI). The author of over 475 peer-reviewed publications, Dr. Suissa serves on the editorial board of various scientific journals including Pharmacoepidemiology and Drug Safety, the European Respiratory Journal, Chest, Lancet Respiratory Medicine and is Section Head editor for F-1000 Medicine. He was an elected member of the boards of directors of the International Society of Pharmacoepidemiology and of the Canadian Association for Pharmaceutical Therapeutics.
Dr. Suissa has received Chercheur-Boursier awards from the FRSQ, a Senior Scientist award from the Medical Research Council of Canada (MRC) and the Distinguished Scientist award from CIHR. He is a fellow of the Canadian Academy of Health Science, has received the FC Donders Professor Award from the Universiteit Utrecht, Netherlands, and currently holds a James McGill Professor Chair from McGill University.
Dr. Suissa is the Principal Investigator of CNODES.